Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Keybanc Maintains Overweight on MKS, Raises Price Target to $180

Author: Benzinga Newsdesk | November 07, 2025 09:48am
Keybanc analyst Steve Barger maintains MKS (NASDAQ:MKSI) with a Overweight and raises the price target from $160 to $180.

Posted In: MKSI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist